Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study: efficacy and safety of telmisartan 20, 40 or 80 mg versus hydrochlorothiazide 12.5 mg or placebo

de, Z., Koster, J., Manolis, A., Murphy, M., Reid, J. and Seewaldt-Becker, E. (2004) Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study: efficacy and safety of telmisartan 20, 40 or 80 mg versus hydrochlorothiazide 12.5 mg or placebo. Journal of Hypertension, 22, pp. 1033-1037. (doi: 10.1097/01.hjh.0000098301.94994.d5)

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Reid, Professor John
Authors: de, Z., Koster, J., Manolis, A., Murphy, M., Reid, J., and Seewaldt-Becker, E.
College/School:College of Medical Veterinary and Life Sciences
Journal Name:Journal of Hypertension

University Staff: Request a correction | Enlighten Editors: Update this record